(Q28248361)

English

Efficacy and tolerability of the novel triple reuptake inhibitor amitifadine in the treatment of patients with major depressive disorder: a randomized, double-blind, placebo-controlled trial

scientific article

Statements

Efficacy and tolerability of the novel triple reuptake inhibitor amitifadine in the treatment of patients with major depressive disorder: a randomized, double-blind, placebo-controlled trial (English)
0 references
Pierre Tran
0 references
Phil Skolnick
0 references
Pal Czobor
0 references
N Y Huang
0 references
Mark Bradshaw
0 references
Anthony McKinney
0 references
January 2012
0 references
46
0 references
1
0 references
64-71
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit